Shin Nishio

39PUBLICATIONS
196CO-AUTHORS
Predictive and prognostic markersEpidemiological methodsWastewater treatment processesCancer therapy (excl. chemotherapy and radiation therapy)Biomechanical engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Aug 07, 2026
Real-world safety and effectiveness of olaparib maintenance after first-relapse platinum-sensitive ovarian cancer in Japan: a multicenter historical cohort (JGOG3026).

|Jul 30, 2026
Neoadjuvant olaparib and pembrolizumab combination therapy in the treatment of patients with HRD-positive advanced ovarian cancer: A pilot study.

|Apr 07, 2026
Plain language summary of results from the DUO-E study: durvalumab given with or without olaparib in patients with advanced endometrial cancer.

Shannon N Westin, Kathleen Moore, Hye Sook Chon

|Feb 19, 2026
Lenvatinib plus pembrolizumab in previously treated advanced endometrial cancer: 5-year outcomes from the randomized, phase 3 Study 309/KEYNOTE-775.

Vicky Makker, Nicoletta Colombo, Antonio Casado

|Sep 20, 2025
A new hyaluronate gel spacer and injection technique for cervical cancer brachytherapy: a technical report.

Yusaku Miyata, Etsuyo Ogo, Kenta Murotani

|Sep 19, 2025
Atezolizumab, bevacizumab, and platinum chemotherapy in cervical cancer: results of Japanese population from BEATcc.

Munetaka Takekuma, Shin Nishio, Satoshi Yamaguchi

Pageof 7

Frequent Collaborators

6 joint publications

Kazuhiro Takehara

5 joint publications

Munetaka Takekuma

5 joint publications

Aikou Okamoto

4 joint publications

Nishino Koji